Canopy Growth (CGC) Exchange Rate Effect (2019 - 2025)
Canopy Growth (CGC) reported Exchange Rate Effect of -$4.8 million for Q4 2025, down 226.58% on a YoY basis from $3.8 million in Q4 2024, and up 16.11% sequentially from -$5.8 million in Q2 2025.
Canopy Growth (CGC) Exchange Rate Effect (2019 - 2025) Analysis & Trends
Canopy Growth (CGC) has 7 years of Exchange Rate Effect data on file, last reported at -$4.8 million in Q4 2025.
- For the quarter ending Q4 2025, Exchange Rate Effect fell 226.58% year-over-year to -$4.8 million; the trailing twelve-month figure through Dec 2025 stood at -$6.7 million (down 215.28% YoY), and the FY2026 full-year result was -$3.5 million, down 128.04% from the prior year.
- Exchange Rate Effect improved to -$4.8 million in Q4 2025, from -$5.8 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $27.9 million in Q3 2022 to a low of -$12.0 million in Q1 2022.
- A 5-year average of $171247.1 and a median of -$201976.3 in 2024 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect jumped 732.99% in 2024 and sank 988.39% in 2025, its largest moves.
- Tracing CGC's Exchange Rate Effect over 5 years: stood at -$502181.7 in 2021, then slumped by 825.83% to -$4.6 million in 2022, then surged by 86.98% to -$605257.3 in 2023, then surged by 732.99% to $3.8 million in 2024, then plunged by 226.58% to -$4.8 million in 2025.
- Business Quant data shows CGC's Exchange Rate Effect at -$4.8 million in Q4 2025, -$5.8 million in Q2 2025, and $3.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.85 Mn |
| Dec 31, 2025 | -4.85 Mn |
| Jun 30, 2025 | -5.78 Mn |
| Jun 30, 2025 | -5.78 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Dec 31, 2024 | 3.83 Mn |
| Sep 30, 2024 | 98,229.16 |
| Sep 30, 2024 | 98,229.16 |
| Jun 30, 2024 | 650,715.09 |
| Jun 30, 2024 | 650,715.09 |
| Mar 31, 2024 | 1.23 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | -605,257.27 |
| Dec 31, 2023 | -605,257.27 |
| Sep 30, 2023 | 1.79 Mn |
| Sep 30, 2023 | 1.79 Mn |
| Jun 30, 2023 | -3.38 Mn |
| Jun 30, 2023 | -3.38 Mn |
| Mar 31, 2023 | 837,336.29 |
| Mar 31, 2023 | 837,336.29 |